Methadone maintenance program in a Swiss perinatal center: (I): Management and outcome of 89 pregnancies

Acta Obstetricia et Gynecologica Scandinavica

Volumn 84, Issue 2, 2005, Pages 140-144

  Kashiwagi, Maki ^a   Arlettaz, Romaine ^b   Lauper, Urs ^a   Zimmermann, Roland ^a   Hebisch, Gundula ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Heroin assisted treatment; Maintenance program; Methadone; Opiate; Pregnancy

Indexed keywords

COCAINE; DIAMORPHINE; ILLICIT DRUG; METHADONE; OPIATE; STREET DRUG;

ABSCESS; ADULT; ARTICLE; BIRTH WEIGHT; COCAINE DEPENDENCE; DELIVERY; DIARRHEA; FEMALE; FETOMATERNAL COMPLICATION; FETUS DISTRESS; HEALTH PROGRAM; HEROIN DEPENDENCE; HUMAN; INCIDENCE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MATERNAL DISEASE; METHADONE TREATMENT; MULTIPLE DRUG ABUSE; OPIATE ADDICTION; PERINATAL CARE; PREECLAMPSIA; PREGNANCY COMPLICATION; PREMATURE LABOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY TRACT INFECTION; SOLUTIO PLACENTAE; SWITZERLAND; UROGENITAL TRACT INFECTION; UTERINE CERVIX INCOMPETENCE;

ADULT; BIRTH WEIGHT; COCAINE-RELATED DISORDERS; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FETAL DEATH; FETAL DEVELOPMENT; FOLLOW-UP STUDIES; HEROIN DEPENDENCE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LINEAR MODELS; MATERNAL HEALTH SERVICES; METHADONE; OPIOID-RELATED DISORDERS; PERINATAL CARE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PROBABILITY; PROSPECTIVE STUDIES; REGISTRIES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; SWITZERLAND; TREATMENT OUTCOME;

EID: 14044273558     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0001-6349.2005.00497.x     Document Type: Article

References (27)

1. Finnegan LP. Treatment issues for opioid-dependent women during the perinatal period. J Psychoactive Drugs 1991; 23: 191-201.
2. Kandall SR, Albin S, Lowinson J, Berle B, Eidelman AI, Gartner LM. Differential effects of maternal heroin and methadone use on birthweight. Pediatrics 1976; 58: 681-5.
3. Ziegler M, Poustka F, von Loewenich V, Englert E. [Postpartum risk factors in the development of children born to opiate-addicted mothers; comparison between mothers with and without methadone substitution]. Nervenarzt 2000; 71: 730-6.
4. Ostrea EM, Chavez CJ, Strauss ME. A study of factors that influence the severity of neonatal narcotic withdrawal. Pediatrics 1976; 4: 642-5.
5. Hagopian GS, Wolfe HM, Sokol RJ, Ager JW, Wardell JN, Cepeda EE. Neonatal outcome following methadone exposure in utero. J Matern Fetal Med 1996; 5: 348-54.
6. Edelin K, Gurganious L, Golar K, Oellrich D, Kyei-Aboagye K, Hamid M. Methadone maintenance in pregnancy. Consequences to care and outcome. Obstet Gynecol 1988; 71: 399-404.
7. Fischer G. Treatment of opioid dependence in pregnant opiate addicts. Addiction 2000; 95: 1141.
8. Fischer G, Bitschnau M, Peternell A, Eder H, Topiz A. Pregnancy and substance abuse. Arch Women's Mental Health 1999; 2: 57-65.
9. Brown HL, Britton KA, Mahaffey D, Brizendine E, Hielt AK, Turnquest MA. Methadone maintenance in pregnancy: a reappraisal. Am J Obstet Gynecol 1998; 179: 459-63.
10. Kelly JJ, Davis PG, Henschke PN. The drug epidemic: effects on newborn infants and health resource consumption at a tertiary perinatal centre. J Paediatr Child Health 2000; 36: 262-4.
11. Hulse GK, Milne E, English DR, Holman CD. The relationship between maternal use of heroin and methadone and infant birth weight. Addiction 1997; 92: 1571-9.
12. Arlettaz R, Kashiwagi M, Das-kundu S, Fauchēre JC, Lang A, Bucher HU. Methadone maintenance program in pregnancy in a Swiss perinatal center (II): neonatal outcome and social resources. Acta Obstet Gynecol Scand 2005; 84: 145-150.
13. Zuspan FP, Gumpel JA, Mejia-Zelaya A, Madden J, Davis R. Fetal stress from methadone withdrawal. Am J Obstet Gynecol 1975; 122: 43-6.
14. Wagner CL, Katikaneni LD, Cox TH, Ryan RM. The impact of prenatal drug exposure on the neonate. Obstet Gynecol Clin North Am 1998; 25: 169-94.
15. Hume RF Jr, Gingras JL, Martin LS, Hertzberg BS, O'Donnell K, Killam AP. Ultrasound diagnosis of fetal anomalies associated with in utero cocaine exposure: further support for cocaine-induced vascular disruption teratogenesis. Fetal Diagn Ther 1994; 9: 239-45.
16. Dashe JS, Sheffield JS, Olscher DA, Todd SJ, Jackson GL, Wendel GD. Relationship between maternal methadone dosage and neonatal withdrawal. Obstet Gynecol 2002; 100: 1244-9.
17. McCarthy JE, Siney C, Shaw NJ, Ruben SM. Outcome predictors in pregnant opiate and polydrug users. Eur J Pediatr 1999; 158: 748-9.
18. Doberczak TM, Kandall SR, Friedman P. Relationships between maternal methadone dosage, maternal-neonatal methadone levels, and neonatal withdrawal. Obstet Gynecol 1993; 81: 936-40.
19. Mack G, Thomas D, Giles W, Buchanan N. Methadone levels and neonatal withdrawal. J Paediatr Child Health 1991; 27: 96-100.
20. Shinderman M, Maxwell S, Brawand-Amey M, Golay KP, Baumann P, Eap CB. Cytochrome P450A4 metabolic activity, methadone blood concentrations, and methadone doses. Drug Alcohol Depend 2003; 69: 205-11.
21. Drozdick J, Berghella V, Hill M, Kaltenbach K. Methadone trough levels in pregnancy. Am J Obstet Gynecol 2002; 187: 1184-8.
22. Gschwend P, Rehm J, Eschmann S, Uchtenhagen A. [Heroin-assisted treatment of opioid addicts in Switzerland from 1994 to 2001 - utilisation and characteristics of admissions and discharges]. Gesundheitswesen 2003; 65: 75-80.
23. Rehm J, Gschwend P, Steffen T, Gutzwiller F, Dobler-Mikola A, Uchtenhagen A. Feasibility, safety, and efficacy of injectable heroin prescription for refractory opioid addicts: a follow-up study. Lancet 2001; 358: 1417-23.
24. Giles W, Patterson T, Sanders F, Batey R, Thomas D, Collins J. Outpatient methadone programme for pregnant heroin using women. Aust NZJ Obstet Gynaecol 1989; 29: 225-9.
25. Little BB, Snell LM, Klein VR, Gilstrap LC 3rd, Knoll KA, Breckenridge JD. Maternal and fetal effects of heroin addiction during pregnancy. J Reprod Med 1990; 35: 159-62.
26. Fischer G, Etzersdorfer P, Eder H, Jagsch R, Langer M, Weninger M. Buprenorphine maintenance in pregnant opiate addicts. Eur Addict Res 1998; 4: 32-6.
27. Schindler SD, Eder H, Ortner R, Rohrmeister K, Langer M, Fischer G. Neonatal outcome following buprenorphine maintenance during conception and throughout pregnancy. Addiction 2003; 98: 103-10.